Cargando…
Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells
There is a need for agents that eliminate cancer stem cells, which sustain cancer and are also largely responsible for disease relapse and metastasis. Conventional chemotherapeutics and radiotherapy are often highly effective against the bulk of cancer cells, which are proliferating, but spare cance...
Autor principal: | Brown, Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105400/ https://www.ncbi.nlm.nih.gov/pubmed/35563205 http://dx.doi.org/10.3390/ijms23094814 |
Ejemplares similares
-
The RARγ Oncogene: An Achilles Heel for Some Cancers
por: Brown, Geoffrey, et al.
Publicado: (2021) -
Synergistic activation of RARβ and RARγ nuclear receptors restores cell specialization during stem cell differentiation by hijacking RARα-controlled programs
por: Koshy, Aysis, et al.
Publicado: (2022) -
RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells
por: Dabrock, Amanda, et al.
Publicado: (2023) -
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis
por: Bosch, Almudena, et al.
Publicado: (2012) -
RARγ is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation
por: Purton, Louise E., et al.
Publicado: (2006)